Seattle Children's Hospital

Seattle Children's Hospital was paid $219.53M by Medicaid between Jan 2018 and Dec 2024, across 758 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.

33Billing provider infoSEATTLE CHILDREN'S HOSPITAL
SEATTLE, WA 98105

33aNPI1467536276assigned 10/25/2006

33bProvider typeProsthetic/Orthotic Supplier

28Total paid$219.53M

24GClaims3,584,766

24DCodes billed758

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Prosthetic/Orthotic Supplier providers in Washington

Rank by total paid#1 of 15

Median peer was paid$17K

This provider vs. median13,174×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	503,165	$33.64M
2019	477,681	$31.91M
2020	376,290	$22.21M
2021	517,826	$27.90M
2022	565,451	$32.63M
2023	612,111	$37.65M
2024incomplete	532,242	$33.59M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	23%	383,897	339,839	$50.09M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	6.0%	82,210	75,291	$13.15M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.5%	60,514	56,901	$9.86M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.7%	62,202	60,936	$8.13M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.2%	44,843	42,014	$6.95M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	2.7%	38,011	35,438	$5.98M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2.6%	2,767	2,536	$5.78M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.2%	11,511	11,182	$4.93M
42820	Tonsillectomy and adenoidectomy; younger than age 12	2.2%	2,890	2,862	$4.90M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2.0%	2,150	1,376	$4.41M
G0378	Hospital observation service, per hour	1.7%	18,456	17,357	$3.83M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.6%	4,617	4,582	$3.49M

746 more codes

93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	1.5%	7,766	$3.33M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	1.5%	2,710	$3.30M
70551	Magnetic resonance imaging, brain; without contrast material	1.5%	10,186	$3.25M
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	1.4%	20,015	$3.01M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.3%	49,737	$2.78M
96361	Intravenous infusion, hydration; each additional hour	1.2%	5,437	$2.62M
93304		1.0%	5,136	$2.24M
95812		1.0%	4,794	$2.23M
95782		1.0%	2,900	$2.22M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.0%	3,570	$2.20M
99215	Doctor's office visit, returning patient (complex)	<1%	17,453	$2.09M
96415		<1%	4,230	$2.00M
D7140	Extraction, erupted tooth or exposed root	<1%	2,107	$1.95M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,015	$1.82M
54161		<1%	1,722	$1.78M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	9,361	$1.76M
76770		<1%	11,510	$1.72M
93308		<1%	3,663	$1.52M
99213	Doctor's office visit, returning patient (routine)	<1%	14,161	$1.51M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	877	$1.32M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,198	$1.23M
70450	Computed tomography, head or brain; without contrast material	<1%	4,774	$1.20M
93325		<1%	19,613	$1.18M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	9,813	$1.18M
Q3014	Telehealth originating site facility fee	<1%	47,043	$1.16M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	29,869	$1.12M
29075		<1%	3,585	$1.12M
49452		<1%	1,866	$1.11M
96450		<1%	2,627	$1.09M
D2930	Prefabricated stainless steel crown - primary tooth	<1%	672	$1.03M
29450		<1%	2,787	$1.03M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	7,976	$922K
99285	Emergency room visit (most serious)	<1%	7,441	$902K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	20,694	$887K
92555		<1%	17,373	$849K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,166	$817K
92587		<1%	5,708	$814K
29065		<1%	2,612	$811K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	1,701	$803K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,217	$745K
36430		<1%	3,983	$740K
55175		<1%	457	$712K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	13,772	$652K
97162		<1%	10,499	$591K
42830		<1%	333	$578K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,022	$564K
H2020	Therapeutic behavioral services, per diem	<1%	1,032	$547K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	6,528	$533K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,764	$530K
92567		<1%	24,377	$469K
44970		<1%	121	$461K
92523		<1%	3,726	$460K
96112		<1%	739	$459K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	1,704	$433K
12011		<1%	1,598	$416K
97763		<1%	1,741	$412K
95716		<1%	854	$383K
31575		<1%	1,304	$378K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	128	$372K
76536		<1%	2,866	$360K
54360		<1%	418	$346K
72141		<1%	2,315	$326K
17110		<1%	1,072	$322K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,801	$310K
87497		<1%	8,905	$297K
54640		<1%	208	$286K
97166		<1%	4,894	$283K
99203	Doctor's office visit, new patient (routine)	<1%	3,604	$276K
36415	Collection of venous blood by venipuncture	<1%	117,185	$272K
92552		<1%	3,368	$271K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,174	$271K
97535	Self-care/home management training, each 15 minutes	<1%	5,079	$269K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	103,566	$269K
81415		<1%	891	$268K
92553		<1%	3,143	$266K
76885		<1%	2,077	$261K
62252		<1%	2,249	$259K
92611		<1%	4,081	$258K
31622		<1%	242	$237K
87799		<1%	10,039	$228K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	6,869	$226K
93975		<1%	3,532	$226K
92585		<1%	784	$223K
76870		<1%	1,846	$220K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	434	$217K
11900		<1%	660	$209K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	374	$209K
D2330		<1%	215	$209K
92060		<1%	7,398	$208K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	27,927	$206K
97161		<1%	3,754	$205K
95700		<1%	1,395	$192K
29105		<1%	890	$191K
24538		<1%	43	$190K
92557		<1%	1,993	$189K
12001		<1%	709	$189K
43762		<1%	819	$186K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	22,612	$186K
76882		<1%	1,613	$183K
87507		<1%	2,792	$171K
71046	Radiologic examination, chest; 2 views	<1%	21,141	$165K
80069		<1%	22,857	$159K
87631		<1%	7,410	$157K
71250		<1%	1,088	$157K
29405		<1%	465	$155K
90686		<1%	16,268	$145K
96367		<1%	1,975	$143K
82784		<1%	15,965	$142K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	21,290	$141K
92522		<1%	2,331	$136K
81416		<1%	911	$132K
J0475	Injection, baclofen, 10 mg	<1%	263	$130K
49500		<1%	56	$129K
92610		<1%	2,596	$126K
92579		<1%	8,019	$123K
36592		<1%	5,220	$123K
67311		<1%	43	$123K
92582		<1%	7,503	$121K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,446	$121K
81229		<1%	1,169	$121K
84443	Thyroid stimulating hormone (TSH)	<1%	36,759	$116K
73718		<1%	487	$115K
80048	Basic metabolic panel (calcium, ionized)	<1%	13,191	$113K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	325	$113K
80197		<1%	10,650	$112K
80053	Comprehensive metabolic panel	<1%	17,277	$112K
99205	Prolong outpt/office vis	<1%	1,026	$110K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	4,223	$108K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	315	$106K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	946	$105K
76825		<1%	2,561	$103K
80061	Lipid panel	<1%	14,077	$98K
70486		<1%	924	$97K
81479	Unlisted molecular pathology procedure	<1%	2,694	$96K
69210		<1%	2,301	$96K
96409		<1%	6,674	$95K
97164		<1%	2,456	$94K
99001		<1%	27,959	$93K
84439		<1%	20,939	$93K
97760		<1%	2,237	$92K
82248		<1%	34,187	$91K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	20,049	$90K
95816		<1%	366	$89K
83735		<1%	40,577	$88K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	33,382	$88K
97165		<1%	1,535	$88K
80051		<1%	24,233	$87K
82728		<1%	22,322	$86K
83880		<1%	5,524	$83K
D2331		<1%	168	$83K
72170		<1%	8,063	$83K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	9,441	$83K
38220		<1%	98	$82K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	5,119	$81K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	10,870	$81K
93226		<1%	1,885	$80K
93271		<1%	558	$80K
77080		<1%	1,072	$80K
87040		<1%	5,351	$79K
86834		<1%	3,063	$79K
72146		<1%	2,396	$79K
70544		<1%	316	$79K
83970		<1%	3,909	$78K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	386	$78K
20680		<1%	88	$76K
95951		<1%	176	$75K
86923		<1%	4,094	$74K
96375	Therapeutic injection; each additional sequential IV push	<1%	6,560	$74K
24640		<1%	151	$72K
74240		<1%	713	$72K
74018		<1%	5,891	$70K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,633	$68K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	3,403	$64K
82565		<1%	42,058	$64K
88185		<1%	1,047	$64K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,702	$63K
51741		<1%	263	$62K
94010		<1%	4,884	$61K
72082		<1%	5,836	$60K
38222		<1%	80	$60K
84311		<1%	31,509	$57K
84460		<1%	69,525	$57K
86835		<1%	3,068	$56K
82670		<1%	3,588	$56K
Q5120	Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg	<1%	16	$56K
76827		<1%	2,531	$55K
51600		<1%	245	$55K
84305		<1%	4,019	$54K
31624		<1%	67	$53K
73560		<1%	4,675	$53K
J3490	Unclassified drugs	<1%	5,870	$53K
0001A		<1%	1,838	$53K
97750		<1%	1,462	$52K
82947		<1%	8,315	$52K
97803		<1%	2,103	$51K
43760		<1%	186	$51K
97116		<1%	2,003	$51K
93321		<1%	8,630	$50K
11100		<1%	84	$50K
77072		<1%	4,245	$49K
92652		<1%	1,192	$49K
73070		<1%	5,572	$48K
95819		<1%	207	$48K
86140		<1%	30,431	$47K
85027		<1%	23,778	$46K
0002A		<1%	1,239	$46K
93320		<1%	7,739	$46K
86850		<1%	8,367	$45K
92556		<1%	1,010	$44K
74241		<1%	360	$44K
82533		<1%	2,661	$43K
84403		<1%	3,982	$43K
83001		<1%	3,699	$42K
83550		<1%	16,636	$42K
92526		<1%	803	$41K
83002		<1%	4,073	$40K
J3262	Injection, tocilizumab, 1 mg	<1%	126	$39K
88313		<1%	3,506	$38K
83498		<1%	3,239	$37K
86376		<1%	2,400	$37K
82157		<1%	1,111	$37K
83540		<1%	17,293	$37K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	13	$36K
G0379	Direct admission of patient for hospital observation care	<1%	231	$36K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,857	$36K
86356		<1%	2,269	$36K
86481		<1%	2,501	$36K
88307		<1%	1,344	$35K
83655		<1%	3,103	$34K
92524		<1%	618	$34K
97168		<1%	841	$34K
70480		<1%	254	$33K
94060		<1%	2,056	$33K
86359		<1%	3,565	$33K
83036	Hemoglobin; glycosylated (A1C)	<1%	22,766	$33K
86355		<1%	3,059	$32K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,222	$32K
J2704	Injection, propofol, 10 mg	<1%	65,557	$31K
29345		<1%	101	$30K
84450		<1%	27,133	$30K
73610		<1%	5,128	$30K
84520		<1%	30,296	$30K
83520		<1%	5,485	$29K
84075		<1%	32,070	$29K
92609		<1%	439	$29K
62370		<1%	234	$29K
99460		<1%	340	$29K
94726		<1%	939	$28K
20670		<1%	12	$28K
82139		<1%	2,731	$28K
84100		<1%	19,716	$28K
82785		<1%	2,846	$28K
73552		<1%	2,074	$27K
74019		<1%	5,209	$27K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,577	$27K
86360		<1%	2,050	$26K
29125		<1%	86	$26K
86003		<1%	4,841	$26K
97542		<1%	449	$26K
83615		<1%	10,983	$25K
80169		<1%	1,986	$24K
82570		<1%	12,461	$24K
73620		<1%	2,389	$24K
72081		<1%	2,621	$24K
82627		<1%	1,654	$24K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,440	$23K
84146		<1%	2,082	$23K
70543		<1%	52	$23K
10060		<1%	117	$23K
73090		<1%	6,396	$23K
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	<1%	506	$23K
92607		<1%	294	$23K
97163		<1%	431	$23K
73590		<1%	4,242	$23K
87103		<1%	2,887	$22K
82977		<1%	23,259	$22K
99238	Hospital discharge day management, 30 minutes or less	<1%	516	$22K
73630		<1%	4,243	$22K
70360		<1%	3,393	$21K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	10,246	$21K
85610		<1%	14,039	$21K
84630		<1%	2,246	$21K
76942		<1%	244	$20K
86357		<1%	2,382	$20K
85045		<1%	8,982	$20K
93786		<1%	1,612	$20K
94729		<1%	859	$20K
72156		<1%	132	$20K
86900		<1%	8,748	$20K
81001		<1%	28,841	$19K
86812		<1%	1,054	$19K
83883		<1%	1,755	$19K
82040		<1%	12,798	$19K
0071A		<1%	507	$19K
82610		<1%	2,817	$19K
83993		<1%	1,516	$18K
81425		<1%	58	$18K
83918		<1%	1,603	$18K
82657		<1%	2,168	$18K
85652		<1%	25,869	$18K
14040		<1%	55	$17K
72020		<1%	773	$17K
96411		<1%	2,450	$17K
84446		<1%	2,762	$17K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	124	$17K
72195		<1%	381	$17K
84590		<1%	2,823	$17K
88342		<1%	2,170	$16K
86800		<1%	1,699	$16K
74455		<1%	90	$16K
88108		<1%	3,342	$16K
92604		<1%	308	$16K
71275	Computed tomographic angiography, chest, with contrast material	<1%	41	$16K
73080		<1%	2,225	$16K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	31,602	$16K
87077		<1%	13,192	$15K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,134	$15K
73140		<1%	3,089	$15K
70491		<1%	92	$15K
D1351	Sealant - per tooth	<1%	962	$15K
82247		<1%	16,364	$15K
82105		<1%	1,421	$15K
36591		<1%	262	$15K
93225		<1%	1,441	$15K
82310		<1%	12,062	$14K
93296		<1%	392	$14K
73100		<1%	5,138	$14K
82607		<1%	2,378	$14K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	19	$14K
85378		<1%	2,042	$14K
86901		<1%	8,698	$14K
77073		<1%	2,444	$13K
J7030	Infusion, normal saline solution , 1000 cc	<1%	13,856	$13K
0072A		<1%	343	$13K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	543	$13K
86665		<1%	2,642	$13K
73130		<1%	3,659	$13K
69209		<1%	118	$13K
90685		<1%	774	$13K
86160		<1%	4,189	$13K
76377		<1%	3,284	$13K
74181		<1%	63	$13K
86663		<1%	1,588	$12K
73720		<1%	38	$12K
86317		<1%	1,947	$12K
83605		<1%	1,390	$12K
82542		<1%	1,470	$12K
84402		<1%	1,407	$12K
84436		<1%	1,741	$12K
82017		<1%	978	$12K
86341		<1%	1,523	$11K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	11,320	$11K
86337		<1%	713	$11K
83021		<1%	1,152	$11K
0004A		<1%	299	$11K
70250		<1%	1,967	$11K
86364		<1%	5,445	$11K
81403		<1%	140	$11K
86235		<1%	1,036	$10K
72197		<1%	41	$10K
84703		<1%	12,668	$10K
71045	Radiologic examination, chest; single view	<1%	1,352	$10K
82962		<1%	15,515	$10K
83020		<1%	1,552	$10K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	346	$10K
87070		<1%	5,918	$10K
87486		<1%	444	$9K
76800		<1%	71	$9K
72040		<1%	1,079	$9K
83516		<1%	5,964	$9K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,876	$9K
88237		<1%	134	$9K
11104		<1%	28	$9K
92504		<1%	92	$9K
80158		<1%	625	$9K
95811		<1%	12	$9K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	750	$9K
88184		<1%	1,200	$9K
J0690	Injection, cefazolin sodium, 500 mg	<1%	14,129	$9K
J9370	Vincristine sulfate, 1 mg	<1%	4,501	$9K
84255		<1%	1,381	$9K
80076		<1%	2,203	$9K
80195		<1%	783	$9K
81426		<1%	56	$9K
87081		<1%	9,136	$9K
97802		<1%	161	$9K
73110		<1%	2,056	$9K
84156		<1%	6,120	$8K
73600		<1%	1,325	$8K
73562		<1%	1,341	$8K
99243		<1%	135	$8K
86664		<1%	1,589	$8K
93788		<1%	310	$8K
80164		<1%	632	$8K
82525		<1%	947	$8K
C1769	Guide wire	<1%	1,725	$8K
85520		<1%	700	$8K
88264		<1%	134	$8K
85730		<1%	7,207	$8K
85246		<1%	1,579	$7K
83690		<1%	13,738	$7K
82550		<1%	5,406	$7K
72100		<1%	925	$7K
82010		<1%	4,085	$7K
P9073	Platelets, pheresis, pathogen-reduced, each unit	<1%	20	$7K
31231		<1%	43	$7K
80299		<1%	552	$7K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	6,072	$7K
73060		<1%	1,335	$7K
86480		<1%	366	$7K
86902		<1%	1,578	$7K
92133		<1%	1,067	$7K
83789		<1%	1,306	$7K
73030		<1%	1,198	$7K
93971		<1%	57	$6K
81321		<1%	27	$6K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,209	$6K
73218		<1%	28	$6K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,701	$6K
85240		<1%	1,081	$6K
82465		<1%	3,094	$6K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	23,360	$6K
85044		<1%	2,636	$6K
82803		<1%	2,584	$6K
82379		<1%	726	$6K
86038		<1%	3,114	$6K
81003		<1%	15,327	$6K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	3,778	$6K
82140		<1%	1,323	$6K
85245		<1%	1,308	$6K
62270		<1%	17	$6K
82043		<1%	5,492	$5K
95813		<1%	12	$5K
84134		<1%	2,023	$5K
73000		<1%	1,386	$5K
73120		<1%	982	$5K
87581		<1%	465	$5K
87340		<1%	1,888	$5K
84480		<1%	1,495	$5K
87184		<1%	7,739	$5K
85384		<1%	3,395	$5K
J9250	Methotrexate sodium, 5 mg	<1%	2,863	$5K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	102	$5K
86803		<1%	1,625	$5K
84244		<1%	478	$5K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	15,694	$5K
82103		<1%	546	$5K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	148	$5K
82261		<1%	942	$5K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	5,094	$5K
87205		<1%	6,249	$5K
77074		<1%	809	$5K
82390		<1%	784	$5K
86780		<1%	723	$5K
88304		<1%	2,513	$4K
74021		<1%	493	$4K
84681		<1%	753	$4K
17250		<1%	14	$4K
87529		<1%	616	$4K
86706		<1%	1,842	$4K
86644		<1%	547	$4K
72158		<1%	124	$4K
92608		<1%	131	$4K
77001		<1%	30	$4K
87338		<1%	813	$4K
80143		<1%	741	$4K
84478		<1%	4,203	$4K
93976		<1%	28	$4K
76000		<1%	895	$4K
74183		<1%	12	$4K
L2820	Addition to lower extremity orthosis, soft interface for molded plastic, below knee section	<1%	42	$4K
84550		<1%	4,182	$4K
85014		<1%	2,281	$4K
81243		<1%	158	$4K
0111A		<1%	94	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,052	$4K
84484		<1%	658	$4K
82746		<1%	1,040	$4K
83921		<1%	669	$4K
L2840	Addition to lower extremity orthosis, tibial length sock, fracture or equal, each	<1%	69	$4K
87449		<1%	909	$4K
80180		<1%	335	$4K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,564	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,339	$3K
99232	Hospital visit by a doctor, follow-up day	<1%	79	$3K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	97	$3K
83525		<1%	976	$3K
0124A		<1%	111	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,467	$3K
89050		<1%	2,992	$3K
92602		<1%	44	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	9,908	$3K
0081A		<1%	94	$3K
L4361	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf	<1%	832	$3K
88312		<1%	420	$3K
99462		<1%	78	$3K
0112A		<1%	72	$3K
80175		<1%	283	$3K
86774		<1%	534	$3K
92700		<1%	88	$3K
36416		<1%	5,359	$3K
93242		<1%	198	$3K
D1206	Topical application of fluoride varnish	<1%	1,768	$3K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	7,055	$3K
0154A		<1%	67	$3K
0074A		<1%	98	$3K
J9070	Cyclophosphamide, 100 mg	<1%	17	$3K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	1,901	$3K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	46	$3K
0082A		<1%	67	$3K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	564	$3K
97113		<1%	25	$2K
86645		<1%	462	$2K
73660		<1%	665	$2K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	309	$2K
90656		<1%	1,512	$2K
82330		<1%	1,689	$2K
92250		<1%	512	$2K
86225		<1%	1,955	$2K
88311		<1%	744	$2K
36000		<1%	1,635	$2K
84445		<1%	143	$2K
72157		<1%	98	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	360	$2K
87102		<1%	1,048	$2K
80183		<1%	161	$2K
87324		<1%	487	$2K
80179		<1%	684	$2K
51798		<1%	829	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,897	$2K
87181		<1%	3,391	$2K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	374	$2K
92015	Determination of refractive state	<1%	252	$2K
82150		<1%	1,196	$2K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	8,160	$2K
0083A		<1%	46	$2K
88291		<1%	522	$2K
D0220	Intraoral - periapical first radiographic image	<1%	1,530	$2K
73564		<1%	637	$2K
91322		<1%	83	$2K
87075		<1%	2,785	$2K
86787		<1%	550	$2K
87071		<1%	1,630	$2K
D1120	Dental cleaning, child	<1%	1,148	$2K
76010		<1%	658	$2K
82024		<1%	197	$2K
D0230	Intraoral - periapical each additional radiographic image	<1%	1,238	$2K
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	5,732	$2K
51784		<1%	12	$2K
96999		<1%	12	$2K
77076		<1%	84	$2K
J9075	Injection, cyclophosphamide, not otherwise specified, 5 mg	<1%	33	$2K
93243		<1%	198	$2K
D4355		<1%	14	$1K
86431		<1%	1,243	$1K
91321		<1%	53	$1K
93356		<1%	144	$1K
87147		<1%	2,352	$1K
96040		<1%	595	$1K
96113		<1%	596	$1K
86039		<1%	998	$1K
88346		<1%	286	$1K
86147		<1%	176	$1K
87210		<1%	1,571	$1K
86200		<1%	966	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,310	$1K
86308		<1%	1,134	$1K
82085		<1%	968	$1K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	3,981	$1K
92134		<1%	282	$1K
84295		<1%	1,016	$1K
92622		<1%	54	$1K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	22	$1K
92083		<1%	107	$1K
93000		<1%	104	$1K
J0834	Injection, cosyntropin, 0.25 mg	<1%	14	$1K
94644		<1%	2,687	$1K
84481		<1%	261	$1K
82272		<1%	389	$1K
86146		<1%	177	$1K
82104		<1%	208	$1K
85670		<1%	1,019	$986.41
86258		<1%	293	$984.76
85018		<1%	459	$959.82
90480		<1%	176	$948.01
82180		<1%	205	$913.08
80306		<1%	855	$903.80
87088		<1%	1,581	$898.26
80177		<1%	83	$879.12
70370		<1%	31	$878.75
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,037	$878.63
85097		<1%	24	$869.56
87177		<1%	213	$838.71
81406		<1%	42	$837.25
85347		<1%	388	$833.69
86705		<1%	342	$814.14
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	1,563	$760.11
88300		<1%	1,251	$759.47
71550		<1%	54	$727.22
88341		<1%	109	$697.96
96152		<1%	25	$697.17
87045		<1%	140	$692.43
86008		<1%	225	$681.40
87101		<1%	703	$676.36
90472	Immunization administration, each additional vaccine (list separately)	<1%	53	$675.09
0134A		<1%	24	$654.00
J3370	Injection, vancomycin hcl, 500 mg	<1%	858	$653.14
86353		<1%	42	$643.40
D0140	Limited oral evaluation - problem focused	<1%	15	$641.38
93270		<1%	106	$627.04
86648		<1%	85	$625.68
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	58	$605.25
84157		<1%	206	$588.08
82945		<1%	216	$568.25
J8540	Dexamethasone, oral, 0.25 mg	<1%	9,365	$559.67
81405		<1%	26	$558.60
85576		<1%	75	$554.20
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,075	$523.09
J9260	Injection, methotrexate sodium, 50 mg	<1%	236	$520.08
87046		<1%	199	$514.32
87116		<1%	26	$513.23
84466		<1%	92	$512.59
88230		<1%	13	$489.87
69200		<1%	64	$478.40
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	429	$468.42
81404		<1%	26	$466.48
87427		<1%	126	$457.99
89230		<1%	18	$448.95
0054A		<1%	12	$448.00
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	180	$446.41
90715		<1%	54	$402.51
J7120	Ringers lactate infusion, up to 1000 cc	<1%	915	$388.07
81302		<1%	14	$386.03
84702		<1%	172	$384.17
84202		<1%	94	$375.01
86769		<1%	233	$369.61
84155		<1%	538	$356.99
85613		<1%	56	$354.35
84210		<1%	42	$347.39
86704		<1%	77	$346.44
93246		<1%	37	$342.61
74220		<1%	14	$334.87
12051		<1%	12	$323.29
D1110	Prophylaxis - adult	<1%	98	$321.95
86592		<1%	90	$318.61
J1644	Injection, heparin sodium, per 1000 units	<1%	2,309	$313.76
88271		<1%	17	$311.67
83090		<1%	12	$308.53
72070		<1%	66	$306.82
80203		<1%	31	$302.94
90732		<1%	52	$298.11
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	26	$283.73
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	686	$268.36
87536		<1%	14	$266.11
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	18	$264.56
86413		<1%	108	$235.86
86015		<1%	232	$234.41
J7050	Infusion, normal saline solution, 250 cc	<1%	925	$231.51
D0274	Bitewings - four radiographic images	<1%	413	$220.32
82397		<1%	44	$214.90
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	13	$214.31
87328		<1%	38	$207.17
72190		<1%	12	$176.98
94799		<1%	70	$174.93
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	43	$171.80
93247		<1%	37	$171.29
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	221	$166.12
81408		<1%	12	$153.79
82374		<1%	150	$142.05
87305		<1%	32	$139.19
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	638	$137.85
87329		<1%	38	$129.81
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	1,026	$124.13
87641		<1%	12	$123.90
80074		<1%	13	$120.77
J2060	Injection, lorazepam, 2 mg	<1%	170	$120.07
J9100	Injection, cytarabine, 100 mg	<1%	251	$118.29
86703		<1%	25	$116.36
86021		<1%	44	$112.48
87106		<1%	129	$109.35
82232		<1%	15	$98.32
87186		<1%	248	$96.95
86361		<1%	67	$81.66
86688		<1%	26	$78.23
87207		<1%	30	$74.16
86687		<1%	26	$71.39
87640		<1%	12	$70.56
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	557	$59.06
J7507	Tacrolimus, immediate release, oral, 1 mg	<1%	165	$44.69
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	254	$43.20
84145		<1%	171	$40.85
86708		<1%	39	$40.41
86762		<1%	13	$38.15
J1815	Injection, insulin, per 5 units	<1%	994	$37.76
84132		<1%	64	$36.57
82166		<1%	13	$35.61
87220		<1%	192	$30.51
85004		<1%	17	$25.52
85247		<1%	46	$25.07
84300		<1%	12	$18.48
87015		<1%	44	$15.70
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	2,348	$14.29
J7510	Prednisolone oral, per 5 mg	<1%	371	$13.28
85250		<1%	24	$12.39
J1940	Injection, furosemide, up to 20 mg	<1%	43	$8.77
86709		<1%	24	$5.63
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,931	$3.92
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	89	$0.24
91307		<1%	1,073	$0.01
B4088	Gastrostomy/jejunostomy tube, low-profile, any material, any type, each	0%	534	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	215	$0.00
80320		0%	158	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	90	$0.00
96376		0%	30	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	353	$0.00
D4212		0%	16	$0.00
91301		0%	12	$0.00
L3923	Hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	0%	56	$0.00
87206		0%	12	$0.00
91315		0%	67	$0.00
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	0%	32	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	15	$0.00
G0008	Administration of influenza virus vaccine	0%	12	$0.00
A9573	Injection, gadopiclenol, 1 ml	0%	92	$0.00
D0272	Bitewings - two radiographic images	0%	32	$0.00
91305		0%	22	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	16	$0.00
74430		0%	12	$0.00
91312		0%	111	$0.00
L1906	Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf	0%	14	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	132	$0.00
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	0%	159	$0.00
91308		0%	250	$0.00
94645		0%	342	$0.00
76001		0%	27	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	78	$0.00
91300		0%	3,490	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	46	$0.00
91311		0%	201	$0.00
91313		0%	24	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	83	$0.00
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	0%	25	$0.00
L1851	Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf	0%	39	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	42	$0.00
75565		0%	24	$0.00
J1071	Injection, testosterone cypionate, 1 mg	0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBEITEL, SUZANNE (SVP AND CFO)

Same official

Other billing entities under BEITEL, SUZANNE

Full network →

Provider	Location	Paid
Seattle Children's Hospital	Bothell, WA	$32.17M
Seattle Children's Hospital	Seattle, WA	$19.80M
Seattle Children's Hospital	Seattle, WA	$2.79M
Seattle Children's Hospital	Seattle, WA	$1.15M
Seattle Children's Hospital	Seattle, WA	$931K
Seattle Children's Hospital	Seattle, WA	$426K
Seattle Children's Hospital	Seattle, WA	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.